Ling Li
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Diabetes Treatment and Management
Papers in
- Epidemiology 104
- Adipokines, Inflammation, and Metabolic Diseases 64
- Liver Disease Diagnosis and Treatment 22
-
- MicroRNA in disease regulation 16
- Co-authors
- Gangyi Yang (103 shared papers)Mengliu Yang (66 shared papers)Hua Liu (59 shared papers)Guenther H. Boden (22 shared papers)Bruce A. Edgar (2 shared papers)Geneviève Renier (6 shared papers)Xinsheng Gao (1 shared paper)Leslie J. Saucedo (1 shared paper)
- Journals
- Scientific Reports (12 papers)Oncotarget (10 papers)Frontiers in Endocrinology (9 papers)Diabetes (7 papers)PLoS ONE (7 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ling Li
542 papers receiving 17.3k citations
Ling Li's Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 1.8k
- Endocrinology, Diabetes and Metabolism 1.5k
- Molecular Biology 5k
- Endocrine and Autonomic Systems 387
- Nephrology 651
Countries citing papers authored by Ling Li
This map shows the geographic impact of Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Li more than expected).
Fields of papers citing papers by Ling Li
This network shows the impact of papers produced by Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Li. The network helps show where Ling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 563 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance Hit paper breakdown → | 2020 | 665 |
| 2 | Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo Hit paper breakdown → | 2001 | 621 |
| 3 | 2009 | 598 | |
| 4 | 2003 | 552 | |
| 5 | Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials Hit paper breakdown → | 2021 | 499 |
| 6 | 2012 | 473 | |
| 7 | 2018 | 330 | |
| 8 | 2017 | 261 | |
| 9 | 2014 | 236 | |
| 10 | 2015 | 195 | |
| 11 | 2015 | 180 | |
| 12 | 2005 | 165 | |
| 13 | 2007 | 165 | |
| 14 | 2021 | 158 | |
| 15 | 2012 | 155 | |
| 16 | 2007 | 137 | |
| 17 | 2010 | 135 | |
| 18 | 2014 | 127 | |
| 19 | 2012 | 123 | |
| 20 | 2012 | 108 |
About Ling Li
Ling Li is a scholar working on Epidemiology, Cancer Research, Molecular Biology, Endocrinology, Diabetes and Metabolism and Rheumatology, having authored 563 papers that have together received 17.7k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (64 papers), Diabetes Treatment and Management (23 papers), Liver Disease Diagnosis and Treatment (22 papers), Advanced biosensing and bioanalysis techniques (21 papers), Head and Neck Cancer Studies (19 papers), Regulation of Appetite and Obesity (17 papers), MicroRNA in disease regulation (16 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). The work is most often cited by research in Cancer Research (1.8k citations), Endocrinology, Diabetes and Metabolism (1.5k citations), Molecular Biology (5k citations), Endocrine and Autonomic Systems (387 citations) and Nephrology (651 citations). Ling Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Gangyi Yang, Mengliu Yang, Hua Liu, Guenther H. Boden, Bruce A. Edgar, Geneviève Renier, Xinsheng Gao, Leslie J. Saucedo, Jingqiu Cheng and Dongfang Liu. Their work appears in journals such as Scientific Reports, Oncotarget, Frontiers in Endocrinology, Diabetes and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.